Delivery Order SPE2DR25D2206-SPE2DR26F9AB8
Award Date 11/3/25
Potential Completion Date 11/25/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,985.82 delivery order to AmerisourceBergen Drug Corp for the supply of Zoladex 3.6 mg implant syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by September 3, 2025, with performance conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single transaction within AmerisourceBergen's broader federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes valued at $5,578.50 with a firm fixed price contract type. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside competitive award, with performance to occur at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,323.88 to AmerisourceBergen Drug Corp for the supply of Zoladex 3.6 mg implant syringes. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award is...
- The Defense Logistics Agency awarded a $11,757.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of November 10, 2025. This non-set-aside contract was competitively awarded on October 20, 2025, with performance to be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,297.50 on August 12, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract carries firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $9,297.50 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This contract, awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zoladex is a hormone treatment used...
- The Defense Logistics Agency awarded a $25,379 delivery order contract to Amerisourcebergen Drug Corporation for the supply of Zoladex 10.8 mg implant syringes. As the prime contractor, Amerisourcebergen will provide the specified pharmaceutical products for use by the Department of Defense from its facility in Conshohocken, Pennsylvania. The firm fixed price contract runs from August 15, 2023 to September 6, 2023 and was issued under an existing DLA pharmaceutical supply vehicle. No...
- The Defense Logistics Agency awarded a $5,578.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 10.8 milligram Zoladex implant syringes, with a completion date of June 25, 2025. This is a non-set-aside contract classified as a child delivery order, indicating it is issued under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $11,157. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZOLADEX 3.6 mg implant syringes under a firm fixed price contract valued at $1,323.88. This non-set-aside award, issued on July 31, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be delivered to...